- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: N.159
- Chain C: S.213, P.215, R.216, N.219
- Ligands: NAG.8
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.216
- Water bridges: C:R.216
NAG-NAG-BMA.10: 6 residues within 4Å:- Chain C: N.159
- Chain E: S.213, P.215, R.216, N.219
- Ligands: NAG.16
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:R.216
- Water bridges: E:R.216
NAG-NAG-BMA.18: 6 residues within 4Å:- Chain A: S.213, P.215, R.216, N.219
- Chain E: N.159
- Ligands: NAG.24
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.216
- Water bridges: A:R.216
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 5 residues within 4Å:- Chain A: S.39, N.279, V.291, N.292
- Chain B: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 5 residues within 4Å:- Chain C: S.39, N.279, V.291, N.292
- Chain D: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 5 residues within 4Å:- Chain E: S.39, N.279, V.291, N.292
- Chain F: E.69
No protein-ligand interaction detected (PLIP)- 3 x NAG- GAL- NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-GAL-NAG-GAL-SIA.4: 15 residues within 4Å:- Chain A: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, F.153, H.177, F.187, L.188, R.216, N.219, I.220, S.222
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.187, A:L.188, A:W.147, A:T.149, A:L.188
- Water bridges: A:D.184, A:D.184, A:T.129
- Hydrogen bonds: A:R.216, A:R.216, A:N.219, A:N.219, A:T.129, A:S.131, A:S.222, A:S.222
NAG-GAL-NAG-GAL-SIA.12: 15 residues within 4Å:- Chain C: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, F.153, H.177, F.187, L.188, R.216, N.219, I.220, S.222
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.187, C:L.188, C:W.147, C:T.149, C:L.188
- Water bridges: C:D.184, C:D.184, C:T.129
- Hydrogen bonds: C:R.216, C:R.216, C:N.219, C:N.219, C:T.129, C:S.131, C:S.222, C:S.222
NAG-GAL-NAG-GAL-SIA.20: 15 residues within 4Å:- Chain E: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, F.153, H.177, F.187, L.188, R.216, N.219, I.220, S.222
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:F.187, E:L.188, E:W.147, E:T.149, E:L.188
- Water bridges: E:D.184, E:D.184, E:T.129
- Hydrogen bonds: E:R.216, E:R.216, E:N.219, E:N.219, E:T.129, E:S.131, E:S.222, E:S.222
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 4 residues within 4Å:- Chain A: N.16, T.18, T.31, N.32
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.16
- Water bridges: A:N.32
NAG.6: 3 residues within 4Å:- Chain A: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.57, A:Y.88
- Water bridges: A:N.57
NAG.7: 2 residues within 4Å:- Chain A: Q.126, N.127
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.127
- Water bridges: A:Q.126, A:Q.126
NAG.8: 8 residues within 4Å:- Chain A: A.157, L.158, N.159, N.240, S.241, T.242
- Chain C: I.211
- Ligands: NAG-NAG-BMA.2
No protein-ligand interaction detected (PLIP)NAG.13: 4 residues within 4Å:- Chain C: N.16, T.18, T.31, N.32
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.16
- Water bridges: C:N.32
NAG.14: 3 residues within 4Å:- Chain C: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.57, C:Y.88
- Water bridges: C:N.57
NAG.15: 2 residues within 4Å:- Chain C: Q.126, N.127
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.127
- Water bridges: C:Q.126, C:Q.126
NAG.16: 8 residues within 4Å:- Chain C: A.157, L.158, N.159, N.240, S.241, T.242
- Chain E: I.211
- Ligands: NAG-NAG-BMA.10
No protein-ligand interaction detected (PLIP)NAG.21: 4 residues within 4Å:- Chain E: N.16, T.18, T.31, N.32
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.16
- Water bridges: E:N.32
NAG.22: 3 residues within 4Å:- Chain E: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.57, E:Y.88
- Water bridges: E:N.57
NAG.23: 2 residues within 4Å:- Chain E: Q.126, N.127
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.127
- Water bridges: E:Q.126, E:Q.126
NAG.24: 8 residues within 4Å:- Chain A: I.211
- Chain E: A.157, L.158, N.159, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.18
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- GAL- NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B